S. Ohnesorge

Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors

M. Pfreundschuh, U. Şahin, C. Renner, 1996, Cancer Immunology, Immunotherapy.

Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells

M. Pfreundschuh, S. Bauer, G. Held, 1997, Cancer Immunology, Immunotherapy.

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.

M. Pfreundschuh, S. Bauer, G. Held, 1996, Blood.

Cells From Patients With Hodgkin ’ s Disease Have a Defective T-cell Receptor 6 Chain Expression That Is Reversible by T-cell Stimulation With CD 3 and CD 28

M. Pfreundschuh, S. Bauer, G. Held, 2002 .

Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo.

M. Pfreundschuh, S. Bauer, G. Held, 1999, Cancer research.

RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells.

M. Pfreundschuh, U. Şahin, S. Bauer, 1997, Journal of immunology.

with CD3 and CD28 receptor zeta chain expression that is reversible by T-cell stimulation T cells from patients with Hodgkin's disease have a defective T-cell

M. Pfreundschuh, S. Bauer, G. Held, 2011 .

Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodies.

M. Pfreundschuh, S. Bauer, G. Held, 1997, Immunobiology.